Mystrika
SPER Market Research is a market intelligence and competitive intelligence firm founded in 2015 and headquartered in Noida, India. The firm provides primary research, competitive intelligence, customer intelligence, industry reports, and strategic consulting across sectors including aerospace and defense, agriculture, and automotive and transportation. Its clients include Astellas, DHL, Microsoft, IQVIA, Bain & Company, Heineken, PwC, and Sanofi.
SPER Market Research is a market intelligence and competitive intelligence firm founded in 2015 and headquartered in Noida, India. The company employs between 100 and 249 people and works with a minimum project budget of $1,000 to $10,000 at an average hourly rate of $25.
The firm offers a suite of research services including primary research, competitive intelligence, customer intelligence, industry reports, and strategic consulting. It states a commitment to data accuracy and innovation, providing customized solutions tailored to each client's research requirements.
SPER Market Research serves sectors including aerospace and defense, agriculture, and automotive and transportation, with client names suggesting additional strength in pharmaceuticals and healthcare. Trusted brands include Astellas, DHL, Microsoft, IQVIA, Bain & Company, Heineken, PwC, and Sanofi.
The firm holds a 4.8 Google rating from 71 reviews. Reviewers highlight customer relations, client satisfaction, informative pharma seminars and webinars, and authentic research-based analytics that help leaders make informed decisions.
Services
- Market Research
- Primary Research
- Competitive Intelligence
- Customer Intelligence
- Industry Reports
- Strategic Consulting
Industries Served
Team Size
Pros
- Holds a 4.8 Google rating from 71 reviews
- Trusted by major global brands such as Microsoft, DHL, PwC, and Sanofi
- Reviewers highlight strong customer relations, client satisfaction, and quality analytics
Client Review Analysis
Google reviewers rate the firm 4.8 out of 5, praising its customer relations, client satisfaction, informative pharma community programs, and authentic research-based data for leadership decisions.